|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
547
|
Thu, 8/6/09, 8:30 AM - 10:20 AM | CC-204B |
| Considerations on Design and Analysis for Multi-Regional Trials - Topic Contributed - Papers | ||
|
Biopharmaceutical Section |
||
| Organizer(s): Yoko Tanaka, Eli Lilly and Company | ||
| Chair(s): Yoko Tanaka, Eli Lilly and Company | ||
| 8:35 AM |
Considerations on Criteria for Consistency Across Regions in Multi-Regional Trials —  Kimitoshi Ikeda, Novartis Pharma K.K.
|
|
| 8:55 AM |
Issues in Evaluating Multiregional Clinical Trials — Yuki Ando, Pharmaceuticals and Medical Devices Agency
|
|
| 9:15 AM |
Prediction of Fracture Risk Based Upon Baseline Characteristics — Kyoungah See, Eli Lilly and Company
|
|
| 9:35 AM |
Sample Size Considerations for Japanese Patients in a Multi-Regional Trial Based on MHLW Guidance — Hui Quan, sanofi-aventis; Peng-Liang Zhao, sanofi-aventis; Ji Zhang, sanofi-aventis; Martin Roessner, sanofi-aventis; Kyo Aizawa, sanofi-aventis
|
|
| 9:55 AM | Disc: James Hung, FDA | |
| 10:15 AM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |